Because emergencies don’t care who your wireless provider is, T-Mobile (NASDAQ: TMUS) is making sure 911 access is available to as many people as possible.
Valvoline Inc. (NYSE: VVV), a leading worldwide supplier of premium branded lubricants and automotive services, today released its 2017 Corporate Social Responsibility Report (CSR). The foundational pillars of corporate social responsibility at Valvoline™ continue to center on its “People, Product and Planet” approach with a strategic focus on achieving greater impact in the areas of citizenship, sustainability, and diversity and inclusion.
Official production of the Subaru Ascent, a new three-row SUV that will seat up to eight passengers, began at Subaru’s Lafayette, Indiana plant yesterday. To mark the occasion, members of the famous Subaru canine family, The Barkleys, visited SIA to welcome the family vehicle to the Subaru line-up. In addition, SIA presented $8,000 in grants to four local nonprofit organizations focused on animal welfare: Almost Home Humane Society, Loving Heart Animal Shelter, Natalie’s Second Chance No-Kill Dog Shelter and North Central Indiana Spay & Neuter.
When Common Impact’s clients ask me what events they should attend to understand the next generation of CSR, employee engagement and for-purpose business, I always point them to the Shared Value Initiative (SVI). SVI held its annual summit this past week in the (finally sunny!) downtown NYC, where hundreds of business, investment and social sector professionals met to hear and discuss the latest in driving a social, environmental and financial bottom line at once.
Jeremy Heimans and Henry Timms have written a new book entitled New Power: How Power Works in our Hyperconnected World and How to Make it Work for You, which builds off a Harvard Business Review article, Understanding New Power, written by these authors in 2014. Jeremy Heimans is a co-founder and CEO of Purpose, a social business that builds movements, and Henry Timms is executive director of the 92nd Street Y and one of the co-founders of Giving Tuesday in 2012.
Two of GRI's governance bodies closely linked to the standard-setting activities are looking for new members. Find out more and submit your nomination before deadline!
Alcon, the global leader in eye care and a division of Novartis, today announced Alcon Cares Project 100, which aims to reduce cataract blindness by providing equipment to perform phacoemulsification (or “phaco”), a key step in the cataract surgery procedure. Alcon Cares, a foundation that oversees equipment and product donations to those in need, will give 100 reprocessed Infiniti units to eligible clinics in Asia, Central and South America, and Africa over the next three years, making it one of the largest eye care equipment donations of its kind.
Next week former EPA Administrator Gina McCarthy will keynote a gathering of top corporate environmental leaders as they discuss their work to build business systems that put environmental, health and safety protection at the core. She shared a preview of her remarks with us, along with her advice for those who are making the business case for environmental protection from within companies today.
capABLE, an employee resource group at Consumers Energy, aims to remove barriers, open minds, and create pathways to meaningful work for current and future employees of all abilities.
Like other CSR elements, Cause Marketing efforts can directly influence your bottom line. Consumers are asking companies to support social and environmental issues, taking action towards areas that may not be relevant to everyday business operations.
Learn how you can apply three volunteer engagement best practices, taken from organizations who rely on volunteers to accomplish their mission. The result? Higher employee participation rates and employee volunteer engagement.
Trane Technologies is a global climate innovator with a clear purpose to boldly challenge what’s possible for a sustainable world. See how embedding...
Showcase Action Against Hunger’s pioneering role in advancing malnutrition treatment—from early therapeutic formulas (F100, F75) to ongoing innovation...
